• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by MetLife Inc.

    9/19/25 6:35:56 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000728618
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    METLIFE INC
    SEC File Number
    001-15787
    Address of Issuer
    200 Park Avenue
    New York
    NEW YORK
    10016
    Phone
    212-578-2211
    Name of Person for Whose Account the Securities are To Be Sold
    Separate Account II
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Bernstein Institutional Services LLC
    245 Park Ave
    New York � NY � 10167
    645060.4866502605409/19/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock12/17/2019PurchaseBANK OF AMERICACheckbox not checked6412/19/2019Cash

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    MetLife 401k Plan Trust-Large Cap Equity Index
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/20/202554743327.87
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/20/202536028515.6
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/20/20251018000.21
    Separate Account 149
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/20/2025272138.67
    MetLife 401k Plan Russell 1000 Value
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/27/2025102482298.88
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock07/28/202536027957.6
    MetLife 401k Plan Trust-Large Cap Equity Index
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock07/31/202520915873.55

    144: Remarks and Signature

    Remarks
    Date of Notice
    09/19/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Mirsad Usejnoski

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MET alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    9/16/2025$95.00Outperform
    Wolfe Research
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    More analyst ratings

    $MET
    SEC Filings

    View All

    MetLife Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - METLIFE INC (0001099219) (Filer)

    9/22/25 8:01:55 AM ET
    $MET
    Life Insurance
    Finance

    SEC Form 144 filed by MetLife Inc.

    144 - METLIFE INC (0001099219) (Subject)

    9/19/25 6:47:19 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 144 filed by MetLife Inc.

    144 - METLIFE INC (0001099219) (Subject)

    9/19/25 6:40:46 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hubbard Robert Glenn was granted 663 shares, increasing direct ownership by 0.66% to 101,151 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    9/11/25 4:02:44 PM ET
    $MET
    Life Insurance
    Finance

    Director Harris Carla A was granted 30 shares, increasing direct ownership by 0.35% to 8,514 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    9/11/25 4:02:30 PM ET
    $MET
    Life Insurance
    Finance

    Director Mckenzie Diana was granted 158 shares, increasing direct ownership by 0.72% to 22,223 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    9/11/25 4:02:37 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Top 20 Companies Recognized in Labrador Transparency's 2025 U.S. Transparency Awards

    Lowe's Companies recognized as a leader in corporate disclosure transparency. Lowe's Companies, Dow, American Express, ConocoPhillips, and AIG secured top honors in the 2025 U.S. Transparency Awards announced today by Labrador Transparency, a leading global communications firm specializing in transparent corporate disclosure documents. The rankings are determined through a rigorous evaluation of corporate disclosure documents and celebrate companies dedicated to building investor and stakeholder trust through clear, concise, and effective communication. "Companies that commit to openness see rewards in the form of higher investor engagement, stronger alliances, and improved voting resul

    9/16/25 8:29:00 AM ET
    $AIG
    $AXP
    $COP
    Life Insurance
    Finance
    Finance: Consumer Services
    Integrated oil Companies

    MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

    MetLife, Inc. (NYSE:MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.00002 percent of MetLife's shares of common stock outstanding as of August 31, 2025. Potemkin's offer price of $53.00 per share is approximately 34.42 percent lower than the $80.82 closing price of MetLife common stock on September 12, 2025. MetLife does not endorse Potemkin's unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Potemkin's offer because the offer is at a price that

    9/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Launches Cancer Support Benefit to Help Employees Understand and Navigate Care Options as Cancer Diagnoses Continue to Rise

    Through a strategic collaboration with Private Health Management, new offering provides individuals with expert-guided cancer education and financial support MetLife has introduced a new Cancer Support benefit to help employees with personalized advice and attention from diagnosis to treatment and through recovery. Through a strategic relationship with Private Health Management, a leader in complex care navigation, MetLife will expand its Critical Illness Insurance offering to provide a more robust cancer benefit, including access to top oncology specialists, tech-enabled and expert-led coordination, and patient counseling – all of which help to provide a clearer path forward for patients

    9/4/25 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded MetLife from Overweight to Neutral and set a new price target of $84.00

    9/19/25 8:25:43 AM ET
    $MET
    Life Insurance
    Finance

    Wolfe Research initiated coverage on MetLife with a new price target

    Wolfe Research initiated coverage of MetLife with a rating of Outperform and set a new price target of $95.00

    9/16/25 8:09:09 AM ET
    $MET
    Life Insurance
    Finance

    BMO Capital Markets initiated coverage on MetLife with a new price target

    BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

    1/23/25 7:50:09 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

    Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

    1/8/25 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Names Kerry O'Brien Global Head of Insurance Asset Management and Liability Solutions

    MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh

    12/2/24 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Worldwide Benefits and GeoBlue® to Offer Joint Solution

    Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

    6/25/24 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Announces Full Redemption of Series G Preferred Stock

    Full Redemption of 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G MetLife, Inc. (NYSE:MET) today announced that it will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, liquidation preference of $1,000 per share ("Series G Preferred Stock"), at a redemption price of $1,000 per share of Series G Preferred Stock. All outstanding shares of Series G Preferred Stock will be redeemed on the dividend payment date of September 15, 2025. Regular dividends on the outstanding shares of Series G Preferred Stock of $19.250 per share will be paid separately on September 15, 2025, to holders of record as of the close of business o

    9/2/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces 2Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results.   Earnings       Return     Per Share       on Equity (ROE)     2Q 2025       2Q 2025                         Net Income $1.03 ROE 11.7%                       Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance